Recently, the University of Saint Joseph’s (USJ) Assistant Professor of Pharmacy Alexander Levine, Pharm.D., BCPS, spoke about his latest research on the American College of Clinical Pharmacy’s (ACCP) podcast.
During the episode, Dr. Levine shared his work, which was published in the September issue of Pharmacotherapy, an official journal of the American College of Clinical Pharmacy. Focusing on the use of the medicine gabapentin for alcohol withdrawal syndrome, Dr. Levine offered insight into his research, including the challenges associated with the standard treatment of benzodiazepines, the specific research aims of his project, and the main results of the study.
“Gabapentin is a promising adjunctive medication to use in the hospital for alcohol withdrawal syndrome,” he said. “Our study demonstrated that patients who receive high doses of gabapentin in the early stages of withdrawal required less overall benzodiazepines, had a faster stabilization of withdrawal symptoms, and a shorter length of hospital stay compared to the control group.”